<DOC>
	<DOCNO>NCT02860559</DOCNO>
	<brief_summary>This study stem cell transplantation TBX-1400 pediatric subject severe combine immunodeficiency ( SCID ) . The donor cell expose protein show laboratory improve ability donor cell make blood immune cell transplant . Exposure donor cell protein modify gene cell way . This study two goal . The first goal find transplant TBX-1400 safe . The second goal find effect TBX-1400 stem cell time engraftment pediatric subject SCID . The study hypothesis TBX-1400 cell shorten time immune reconstitution transplant .</brief_summary>
	<brief_title>Safety Early Efficacy Study TBX-1400 Patients With Severe Combined Immunodeficiencies</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Severe Combined Immunodeficiency</mesh_term>
	<criteria>Signed informed consent subject 's legally authorize representative ( case , parent parent ) , Age 1 month 4 year , SCID , leaky SCID &lt; 100 TRECs , Omenn syndrome require stem cell transplant conditioning therapy ( patient decrease Tcell number flow cytometry , decrease TREC , decrease vitro response T cell mitogen eligible regardless Bcell and/or natural killer ( NK ) cell function ) , Identified donor ( 9 10/10 Human Leukocyte Antigen ( HLA ) match unrelated haplocompatible relative ) , Eligible patient must adequate physical function tolerate condition regimen hematopoietic stem cell transplantation ( HSCT ) , measure : Renal function : serum creatinine ≤3x upper limit normal age , Hepatic function : adequate synthetic function indicate serum fibrinogen normal limit child 's age , Cardiac function : leave ventricular ejection fraction ≥28 % determined echocardiography . ( For subject leave ventricular ejection fraction [ LVEF ] exactly 28 % , condition delay reason , repeat echocardiogram perform condition regimen initiate confirm subject 's continued eligibility participation study . ) Lack investigational review board ( IRB ) approval study treat institution , Lack consent child 's legal guardian ( Israeli law require consent parent ) , Adenosine deaminase ( ADA ) deficiency , Subject suitable , available match sibling donor , Endstage organ failure precludes ability tolerate transplant procedure conditioning , Serum creatinine &gt; 3 time upper limit normal age , Left ventricular ejection fraction &lt; 28 % determined echocardiography , Inadequate hepatic synthetic function indicate serum fibrinogen normal child 's age sign hepatic failure , Major congenital abnormality adversely affect survival , Expected survival &lt; 4 week despite transplant . The follow NOT exclusion criterion : The administration supplemental oxygen , The presence infection per se , patient SCID frequently infections routine pathogen well opportunistic infection . Antibiotic , antifungal antiviral prophylaxis therapy use clinically indicate . Because transplantation require control infection , subject may enrol study even though infection present although acute infection control prior initiate transplant conditioning . Adjudication control infection perform physician ( ) treat patient together clinical Principal Investigator study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>4 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>Severe Combined Immunodeficiency</keyword>
</DOC>